Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
Applied DNA Sciences (NASDAQ:APDN) has announced the rescheduling of its Investor Update call from January 9, 2025, to Thursday, February 13, 2025. The rescheduling aligns with the release of the company's first quarter fiscal 2025 financial results. The original call was intended to provide shareholders with updates on the company's strategic restructuring announced in December 2024 and GMP initiative. The schedule change is due to the observance of the National Day of Mourning in recognition of the passing of former President Jimmy Carter.
Applied DNA Sciences (NASDAQ:APDN) ha annunciato che la sua chiamata per l'aggiornamento agli investitori è stata riprogrammata dal 9 gennaio 2025 a giovedì 13 febbraio 2025. Questo cambiamento di programma si allinea con la pubblicazione dei risultati finanziari del primo trimestre fiscale 2025 dell'azienda. La chiamata originale era destinata a fornire agli azionisti aggiornamenti sulla ristrutturazione strategica dell'azienda annunciata nel dicembre 2024 e sull'iniziativa GMP. Il cambiamento di programma è dovuto all'osservanza della Giornata Nazionale di Lutto in riconoscimento della scomparsa dell'ex Presidente Jimmy Carter.
Applied DNA Sciences (NASDAQ:APDN) ha anunciado la reprogramación de su llamada de Actualización para Inversores del 9 de enero de 2025 al jueves 13 de febrero de 2025. Esta reprogramación se alinea con la publicación de los resultados financieros del primer trimestre fiscal de 2025 de la compañía. La llamada original tenía la intención de proporcionar a los accionistas actualizaciones sobre la reestructuración estratégica de la compañía anunciada en diciembre de 2024 y la iniciativa GMP. El cambio de horario se debe a la observancia del Día Nacional de Luto en reconocimiento al fallecimiento del ex Presidente Jimmy Carter.
Applied DNA Sciences (NASDAQ:APDN)는 투자자 업데이트 전화 를 2025년 1월 9일에서 2025년 2월 13일 목요일로 재조정했다고 발표했습니다. 이 재조정은 회사의 2025 회계연도 1분기 재무 결과 발표와 일치합니다. 원래 전화는 2024년 12월에 발표된 회사의 전략적 구조 조정 및 GMP 이니셔티브에 대한 업데이트를 주주에게 제공하기 위한 것이었습니다. 일정 변경은 고(故) 제임스 카터 대통령의 서거를 기리기 위한 국가 애도일에 대한 준수로 인한 것입니다.
Applied DNA Sciences (NASDAQ:APDN) a annoncé le report de son appel de mise à jour des investisseurs du 9 janvier 2025 au jeudi 13 février 2025. Ce report coïncide avec la publication des résultats financiers du premier trimestre de l'exercice 2025 de la société. L'appel initial visait à fournir aux actionnaires des mises à jour sur la réorganisation stratégique de l'entreprise annoncée en décembre 2024 et sur l'initiative GMP. Le changement de programme est dû à l'observance de la Journée Nationale de Deuil en reconnaissance du décès de l'ancien Président Jimmy Carter.
Applied DNA Sciences (NASDAQ:APDN) hat die Verschiebung seines Investor Update-Calls vom 9. Januar 2025 auf Donnerstag, den 13. Februar 2025, bekannt gegeben. Die Verschiebung steht im Einklang mit der Veröffentlichung der finanziellen Ergebnisse des Unternehmens für das erste Quartal des Haushaltsjahres 2025. Der ursprüngliche Anruf sollte den Aktionären Aktualisierungen zur strategischen Umstrukturierung des Unternehmens, die im Dezember 2024 angekündigt wurde, und zur GMP-Initiative bieten. Die Änderung des Zeitplans ist auf die Beobachtung des Nationalen Trauertags zurückzuführen, um dem verstorbenen ehemaligen Präsidenten Jimmy Carter zu gedenken.
- None.
- None.
STONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it has rescheduled its Investor Update call to Thursday, February 13, 2025, to coincide with the release of its first quarter fiscal 2025 financial results.
The Company originally scheduled an Investor Update call for January 9, 2025, to update shareholders on its strategic restructuring announced in December 2024 and GMP initiative. The change reflects the observance of the National Day of Mourning in recognition of the passing of former President Jimmy Carter.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we currently operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and, (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: https://investors.adnas.com/
SOURCE: Applied DNA Sciences, Inc.
View the original press release on accesswire.com
FAQ
When is Applied DNA's (APDN) rescheduled Investor Update call for Q1 2025?
What was the original date for APDN's Investor Update call?
What topics will be covered in Applied DNA's upcoming Investor Update call?
Why did Applied DNA (APDN) reschedule its January 2025 Investor Update call?
